ARDS (Aridis Pharmaceuticals) Insider Ownership: 5.14 % (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ARDS Aridis Pharmaceuticals Inc ARDS
12 GF Score
Price $0.00
View Full Analysis

What is Aridis Pharmaceuticals Insider Ownership?

Aridis Pharmaceuticals ARDS 12 Insider Ownership is 5.14 % as of Jul. 31, 2026. GuruFocus rates ARDS with a GF Score™ of 12/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aridis Pharmaceuticals's insider ownership is 5.14%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aridis Pharmaceuticals's Institutional Ownership is 1.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aridis Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 85.17%.

Aridis Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Aridis Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aridis Pharmaceuticals Insider Ownership Chart

Aridis Pharmaceuticals Historical Data

The historical data trend for Aridis Pharmaceuticals can be seen below:

2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 5.14 5.14 5.14 5.14 5.14 5.14 5.14 5.14 5.14 5.14
ARDS
12GF Score
Aridis Pharmaceuticals Inc ARDS
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aridis Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 5.14 % mean?
Aridis Pharmaceuticals (ARDS) has a Insider Ownership of 5.14 % as of Jul. 31, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Aridis Pharmaceuticals and its competitors.
Is Aridis Pharmaceuticals' Insider Ownership too high?
Aridis Pharmaceuticals' current Insider Ownership is 5.14 %. Overall, Aridis Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Aridis Pharmaceuticals' Insider Ownership compare to ARTL and REVB?
Aridis Pharmaceuticals' Insider Ownership of 5.14 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Aridis Pharmaceuticals and its competitors. Aridis Pharmaceuticals's current Insider Ownership is 5.14 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aridis Pharmaceuticals stock overvalued right now?
Aridis Pharmaceuticals (ARDS) has a current Insider Ownership of 5.14 %. The current Insider Ownership is 5.14 %. Aridis Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Aridis Pharmaceuticals (ARDS), the current Insider Ownership is 5.14 % as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aridis Pharmaceuticals Business Description

Address 983 University Avenue, Building B, Los Gatos, CA, USA, 95032
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
12GF Score

Get the complete analysis for ARDS

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price